###### Strengths and limitations of this study

-   The study had a high follow-up rate for both the web-based questionnaire and clinical examination.

-   The study included both subjective and objective outcome measurements.

-   All the clinical examinations were performed by the same examiner raising a possible risk of intraobserver bias.

-   There was a risk of recall bias as information about pre-pregnancy sexual function was obtained postpartum.

Introduction {#s1}
============

Sexuality is an important aspect of human identity and contributes significantly to the quality of life in women as well as in men.[@R1] Sexual function postpartum is affected by the changes in hormonal milieu, anatomy and family structure following childbirth. Dyspareunia and other sexual problems, such as loss of sex drive, in the postpartum period is a well-known problem and frequencies of sexual health problems as high as 30%--60% three months postpartum and 17%--31% six months postpartum have been reported.[@R2] A large cohort study from Sweden found vaginal or perineal tears, regardless of degree, to be associated with a delay in women's resumption of sexual intercourse defined as more than 3 months after giving birth,[@R8] while about 10% of primiparous women had not yet resumed sexual intercourse 6 months postpartum.[@R3] The causes of sexual health problems are multifactorial and the mechanisms are still not fully understood.[@R3] Thus, sexual health problems remains an unsolved problem for many women. Among other things, anatomical changes caused by vaginal or perineal tears may contribute to dyspareunia and have important effects on both the timing and quality of the resumption of sexual relations during the initial postpartum months.[@R10] The association between obstetrical risk factors and postpartum sexual function is not yet well-described or understood, and thus, the aim of this study was to investigate the association between degree of perineal tear, sexual function and dyspareunia 12 months postpartum.

Methods {#s2}
=======

Study setting {#s2-1}
-------------

This study is part of a larger prospective cohort study conducted at two universities and two tertiary hospital units in Denmark, Odense (OUH), Aarhus, Esbjerg and Kolding, between July 2015 and January 2019. The inclusion procedure and sample size calculation is described thoroughly elsewhere.[@R11]

Study population {#s2-2}
----------------

The study involved three groups of women (i) 203 women with no/labia/first-degree perineal tears, (ii) 200 women with second-degree perineal tears and (iii) 200 women with third-degree/fourth-degree perineal tears.

Patient and public involvement {#s2-3}
------------------------------

There was no patient or public involvement in the design and conduct of this study.

Inclusion and follow-up procedure {#s2-4}
---------------------------------

Women delivering vaginally, at least 18 years old, and able to read and speak Danish were eligible. After the delivery, they were informed about the study. Further information was sent by email and the women were invited by phone to participate in a face-to-face interview including baseline questionnaires and a clinical examination comprising a perineal inspection at 16±5 days postpartum. Written informed consent was obtained at baseline.[@R11] At 12 months postpartum, all participants received the same questionnaires electronically and were invited to a gynaecological examination. All examinations took place at the hospital and participants could bring their baby. Study data were collected and managed using REDCap electronic data capture tools hosted at OUH.[@R12]

Outcome measurements {#s2-5}
--------------------

The primary outcome was sexual function. We used the Danish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12).[@R13] The PISQ-12 is a self-administered, objective and validated questionnaire with scores based on 12 questions to evaluate sexual function. The score of each item ranges from 0=never to 4=always (reverse scoring for questions 1, 2, 3 and 4). Missing responses are handled by multiplying the mean of answered items and the score is valid with up to two missing answers.[@R13] The questionnaire has previously been used to evaluate sexual function after vaginal delivery.[@R14] We used the total score (range 0--48) with lower scores indicating better sexual function, and the individual score for question 5, 'Do you feel pain during sexual intercourse?'. The total score was used as a continuous variable presented as mean and SD, and the single score for question 5 was dichotomised as dyspareunia when answering 'sometimes', 'usually' or 'always' and no dyspareunia when answering 'seldom' or 'never'.

Exposure variables and covariates {#s2-6}
---------------------------------

### Degrees of perineal tears {#s2-6-1}

The degree of perineal tear was defined according to the Green-top Guideline No. 29.[@R16] First-degree tears were defined as injury to perineal skin and/or vaginal mucosa. Second-degree tears were defined as injury to perineum involving perineal muscles but not the anal sphincter. Third-degree and fourth-degree tears were defined as injury to perineum involving the anal sphincter complex. Episiotomies were lateral or mediolateral. Episiotomies equivalent to a second-degree tear were analysed independently, while episiotomies extending to the anal sphincter muscles were classified as a third-degree/fourth-degree tear.

### Baseline information {#s2-6-2}

At baseline, 16±5 days postpartum, a questionnaire was completed providing information about age (years), height (cm), smoking status (yes/no) and pregestational body mass index (BMI) (kg/m^2^). Information about pregnancy, birth and the postpartum period was obtained from the obstetric journal and included diabetes mellitus (yes/no), length of active birth and length of the second stage of labour (min), operative delivery (yes/no), birth weight (g) and head circumference (cm). The PISQ-12 was likewise completed at baseline providing information about pre-pregnancy sexual function. Question 5 was used and dichotomised as the postpartum score described in section Outcome measurements.

### Clinical examination 12 months postpartum {#s2-6-3}

Perineal length was evaluated by a gynaecological examination. All procedures were done by the first author (DG), with the women in the dorsal lithotomy position without bowel preparation. At the gynaecological examination, perineal body length was measured in centimetres, from the hymen to the middle of the anus during Valsalva manoeuvre as done in the Pelvic Organ Quantification system,[@R17] and used as a dichotomous variable (≤2/\>2 cm).

Statistical analyses {#s2-7}
--------------------

Baseline characteristics according to degree of tear were described as frequencies for categorical variables. To investigate the association between the degree of perineal tear and dyspareunia or perineal body length, a relative risk (RR) regression by use of a generalised linear model with log link function and binomial distribution as statistical family was performed with estimates reported as RRs with 95% CIs. To investigate the association between the degree of perineal tear and sexual health problems measured as the total PISQ-12 score, a linear regression was performed, and results presented as regression coefficients (β) with 95% CIs. In the adjusted analysis, we controlled for pre-pregnancy dyspareunia, smoking, diabetes and operative delivery as categorical variables and age, BMI, duration of the second stage of labour, duration of active birth and birth weight as continuous variables. These potential confounders were chosen a priori based on directed acyclic graphs generated for the outcome variable using DAGitty V.2.3 as a graphical tool for analysing the causal diagrams.[@R18] The analyses were carried out using Stata statistical software V.15.0.

Results {#s3}
=======

Participants {#s3-1}
------------

Initially, a total of 832 women were invited to participate in the study ([figure 1](#F1){ref-type="fig"}). Of these, 81 declined and 138 could not be reached. This left 613 women completing a written consent and a baseline questionnaire who were booked for a clinical examination 16±5 days postpartum. A total of 10 women withdrew their consent. Thus, the study population comprised of 603 women. At the 1 year follow-up, 554 of the 603 women answered the web-based questionnaire corresponding to 92%, and 481 women had the clinical examination performed corresponding to 80%. Due to more than two missing answers, 13 women were excluded from analyses of total PISQ-12 score.

![Flow chart of inclusion and follow-up. Reasons for not participating in the clinical examination: withdrawal of consent/lost to follow-up: 111 women, moved away: 5 women, gave birth again: 5 women and dead: 1 woman.](bmjopen-2019-032368f01){#F1}

Characteristics according to degree of tear {#s3-2}
-------------------------------------------

Women sustaining third-degree/fourth-degree tears were on average 0.5 years older than women sustaining second-degree tears and 1.2 years older than women sustaining no/labia/first-degree tears ([table 1](#T1){ref-type="table"}).

###### 

Characteristics according to degree of tear among primiparous women (n=554)

  -------------------------------------------------------------------------------------
                                    Total\       Group 1      Group 2      Group 3
                                    (n=554)                                
  --------------------------------- ------------ ------------ ------------ ------------
  BMI, pre-pregnancy (kg/m^2^)\*                                           

   \<25                             357 (64.6)   128 (67.0)   116 (61.7)   113 (64.9)

   25--29.9                         126 (22.8)   41 (21.5)    46 (24.5)    39 (22.4)

   ≥29.9                            70 (12.7)    22 (11.5)    26 (13.8)    22 (12.6)

  Age at inclusion (years)                                                 

   ≤25                              141 (25.5)   63 (33.0)    50 (26.5)    28 (16.1)

   26--30                           278 (50.2)   91 (47.6)    89 (47.1)    98 (56.3)

   \>30                             135 (24.4)   37 (19.4)    50 (26.5)    48 (27.6)

  Active birth duration (min)                                              

   \<220                            140 (25.3)   69 (36.1)    46 (24.3)    25 (14.4)

   221--340                         141 (25.5)   45 (23.6)    53 (28.0)    43 (24.7)

   341--570                         143 (25.8)   50 (26.2)    49 (25.9)    44 (25.3)

   \>570                            130 (23.5)   27 (14.1)    41 (21.7)    62 (35.6)

  Second stage duration (min)                                              

   \<16                             109 (19.7)   40 (20.9)    47 (24.9)    22 (12.6)

   16--30                           187 (33.8)   80 (41.9)    60 (31.8)    47 (27.0)

   31--45                           89 (16.1)    31 (16.2)    27 (14.3)    31 (17.8)

   \>45                             169 (30.5)   40 (20.9)    55 (29.1)    74 (42.5)

  Birth weight (g)                                                         

   \<2999                           76 (13.7)    39 (20.4)    23 (12.2)    14 (8.1)

   3000--3499                       193 (34.8)   69 (36.1)    81 (42.9)    43 (24.7)

   3500--3999                       210 (37.9)   64 (33.5)    65 (34.4)    81 (46.6)

   ≥4000                            75 (13.5)    19 (10.0)    20 (10.6)    36 (20.7)

  Head circumference (cm)†                                                 

   \<34                             141 (25.5)   58 (30.5)    52 (27.7)    31 (17.8)

   34                               119 (21.6)   45 (23.7)    37 (19.7)    37 (21.3)

   35                               131 (23.7)   35 (18.4)    53 (28.2)    43 (24.7)

   \>35                             161 (29.2)   52 (27.4)    46 (24.5)    63 (36.2)

  Pre-pregnancy dyspareunia (yes)   107 (19.3)   26 (13.6)    39 (20.6)    42 (24.1)

  Operative delivery (yes)          95 (17.2)    6 (3.1)      29 (15.3)    60 (34.5)

  Episiotomies (yes)                54 (9.8)     --           32 (16.9)    22 (12.6)

  Smoker at inclusion (yes)\*       21 (3.8)     8 (4.2)      8 (4.2)      5 (2.9)

  Diabetes mellitus (yes)           19 (3.4)     5 (2.6)      7 (3.7)      7 (4.0)
  -------------------------------------------------------------------------------------

\*One missing value, n=553.

†Two missing values, n=552.

BMI, body mass index.

Moreover, a higher degree of tear was seen with higher birth weight, longer second stage of labour and longer duration of active birth. Instrumental delivery was more frequent among women with second-degree (15%) and third-degree/fourth-degree tears (34%) compared with women with no/labia/first-degree tears (3%).

Risk of sexual health problems and dyspareunia {#s3-3}
----------------------------------------------

The proportion of pre-pregnancy dyspareunia was 14%, 21% and 24% in the no/labia/first-degree, second-degree and third-degree/fourth-degree tear groups, respectively ([table 1](#T1){ref-type="table"}). At 12 months postpartum, the proportion in all three groups was higher than pre-pregnancy, 25%, 38% and 53%, respectively.

The risks for dyspareunia at 12 months postpartum are presented in [table 2](#T2){ref-type="table"}.

###### 

Relative risks (RRs) for dyspareunia 12 months postpartum among primiparous women in Denmark (n=554)

  ------------------------------------------------------------------------------------------------------------------------------
                                             Total\   Dyspareunia   Crude                                       
                                             n=554                                                              
  ------------------------------------------ -------- ------------- ------------ ------ ---------------- ------ ----------------
  Degree of tear                                                                                                

   No/labia/first                            191      47 (24.6)     144 (75.4)   1.00   reference        1.00   reference

   Second (spontanous)                       157      59 (37.8)     97 (62.2)    1.53   (1.11 to 2.10)   2.05   (1.51 to 2.78)

   Second (mediolateral episiotomy)          32       13 (40.6)     19 (59.4)    1.65   (1.01 to 2.69)   1.62   (0.99 to 2.67)

   Third or fourth                           174      92 (52.9)     82 (47.1)    2.15   (1.62 to 2.86)   2.09   (1.55 to 2.81)

  BMI, pre-pregnancy (kg/m^2^)†, mean (SD)                                                                      

   \<25                                      357      140 (39.2)    217 (60.8)   1.00   reference        1.00   reference

   25--29.9                                  126      50 (39.7)     76 (60.3)    1.01   (0.79 to 1.30)   1.05   (0.82 to 1.36)

   \>29.9                                    70       21 (30.0)     49 (70.0)    0.77   (0.52 to 1.12)   0.82   (0.56 to 1.19)

  Age at inclusion (years), mean (SD)                                                                           

   ≤25                                       141      52 (36.9)     89 (63.1)    0.94   (0.72 to 1.22)   0.94   (0.72 to 1.22)

   26--30                                    278      109 (39.2)    169 (60.8)   1.00   reference        1.00   reference

   \>30                                      135      50 (37.0)     85 (63.0)    0.94   (0.73 to 1.23)   0.91   (0.70 to 1.19)

  Active birth duration (min), mean (SD)                                                                        

   \<220                                     140      49 (35.0)     91 (65.0)    0.97   (0.71 to 1.33)   0.90   (0.66 to 1.24)

   221--340                                  141      51 (36.2)     90 (63.8)    1.00   reference        1.00   reference

   341--570                                  143      52 (36.4)     91 (63.6)    1.00   (0.74 to 1.37)   1.00   (0.74 to 1.37)

   \>570                                     130      59 (45.4)     71 (54.6)    1.26   (0.94 to 1.68)   1.26   (0.92 to 1.70)

  Second stage duration (min), mean (SD)                                                                        

   \<16                                      109      34 (31.2)     75 (68.8)    0.82   (0.59 to 1.15)   0.80   (0.57 to 1.12)

   16--30                                    187      71 (38.0)     116 (62.0)   1.00   reference        1.00   reference

   31--45                                    89       29 (32.6)     60 (67.4)    0.86   (0.60 to 1.22)   0.86   (0.61 to 1.23)

   \>45                                      169      77 (45.6)     92 (54.4)    1.20   (0.94 to 1.54)   1.15   (0.88 to 1.52)

  Birth weight (g), mean (SD)                                                                                   

   \<2999                                    76       31 (40.8)     45 (59.2)    1.05   (0.76 to 1.45)   1.09   (0.79 to 1.51)

   3000--3499                                193      75 (38.9)     118 (61.1)   1.00   reference        1.00   reference

   3500--3999                                210      82 (39.1)     128 (60.9)   1.01   (0.79 to 1.28)   0.96   (0.75 to 1.22)

   ≥4000                                     75       23 (30.7)     52 (69.3)    0.79   (0.54 to 1.16)   0.74   (0.50 to 1.10)

  Pre-pregnancy dyspareunia (yes)            107      66 (31.3)     41 (12.0)    1.90   (1.56 to 2.32)   1.79   (1.45 to 2.21)

  Operative delivery (yes)                   65       45 (47.4)     50 (52.6)    1.31   (1.03 to 1.67)   1.18   (0.90 to 1.54)

  Smoker at inclusion (yes)†                 21       10 (47.6)     11 (52.4)    1.27   (0.80 to 2.01)   1.31   (0.82 to 2.10)

  Diabetes (yes)                             19       7 (36.8)      12 (63.2)    0.97   (0.53 to 1.76)   1.02   (0.56 to 1.88)
  ------------------------------------------------------------------------------------------------------------------------------

\*One missing value (n=553).

†Adjusted for age, BMI, birth weight, second stage duration, active birth duration, smoking, diabetes, operative delivery and pre-pregnancy dyspareunia (second stage duration and active birth duration are not mutually adjusted for each other).

BMI, body mass index.

Compared with women with no/labia/first-degree tears, women with third-degree/fourth-degree tears had a higher risk of dyspareunia (adjusted RR (aRR) 2.09; 95% CI 1.55 to 2.81), as did women with spontaneous second-degree tears (aRR 2.05; 95% CI 1.51 to 2.78). Further, we found pre-pregnancy dyspareunia to be associated with postpartum dyspareunia (aRR 1.79; 95% CI 1.45 to 2.21).

At 12 months postpartum, the mean PISQ-12 score was higher among women with third-degree/fourth-degree tears (12.2) than among women with no/labia/first-degree tears (10.4) ([table 3](#T3){ref-type="table"}).

###### 

Risk for sexual health problems 12 months postpartum among primiparous women in Denmark (n=541)

                                                              PISQ-12 score\*                             
  ---------------------------------------- ----- ------------ ----------------- ----------------- ------- -----------------
  Degree of tear                                                                                          
   No/labia/first                          188   10.4 (4.2)   0                 reference         0       reference
   Second (spontaneous)                    153   10.7 (5.1)   0.37              (−0.65 to 1.38)   0.21    (−0.81 to 1.22)
   Second (mediolateral episiotomy)        31    11.2 (4.2)   0.81              (−0.95 to 2.56)   0.67    (−1.13 to 2.46)
   Third or fourth                         169   12.1 (5.0)   1.80              (0.81 to 2.78)    1.69    (0.61 to 2.76)
  BMI (kg/m^2^)‡, mean (SD)                                                                               
   \<25                                    349   11.2 (4.7)   0                 reference         0       reference
   25--29.9                                121   10.8 (4.8)   −0.44             (−1.43 to 0.56)   −0.23   (−1.22 to 0.76)
   \>29.9                                  70    10.6 (5.4)   −0.60             (−1.83 to 0.64)   −0.51   (−1.74 to 0.72)
  Age (years), mean (SD)                                                                                  
   ≤25                                     137   11.2 (5.1)   0.45              (−0.53 to 1.44)   0.49    (−0.49 to 1.47)
   26--30                                  270   10.8 (4.7)   0                 reference         0       reference
   \>30                                    134   11.5 (4.6)   0.67              (−0.32 to 1.67)   0.61    (−0.37 to 1.59)
  Active birth duration (min), mean (SD)                                                                  
   \<220                                   137   10.9 (4.5)   −0.22             (−1.35 to 0.91)   −0.24   (−1.27 to 0.79)
   221--340                                139   11.1 (5.5)   0                 reference         0       reference
   341--570                                140   10.7 (4.4)   −0.46             (−1.58 to 0.67)   0.55    (−0.57 to 0.47)
   \>570                                   125   11.6 (4.7)   0.51              (−0.65 to 1.67)   0.09    (−1.01 to 1.19)
  Second stage duration (min), mean (SD)                                                                  
   \<16                                    109   10.9 (5.0)   −0.22             (−1.36 to 0.92)   0.30    (−1.44 to 0.84)
   16--30                                  181   11.1 (4.9)   0                 reference         0       reference
   31--45                                  87    10.5 (4.4)   −0.60             (−1.83 to 0.62)   −0.76   (−1.98 to 0.46)
   \>45                                    164   11.5 (4.8)   0.37              (−0.64 to 1.39)   0.05    (−1.00 to 1.11)
  Birth weight (g), mean (SD)                                                                             
   \<2999                                  75    12.3 (4.9)   1.13              (−0.14 to 2.41)   0.99    (−0.27 to 2.27)
   3000--3499                              191   11.2 (4.6)   0                 reference         0       reference
   3500--3999                              205   10.5 (4.8)   −0.66             (−1.60 to 0.28)   −0.73   (−1.68 to 0.21)
   ≥4000                                   70    11.2 (5.1)   0.08              (−1.23 to 1.38)   0.20    (−1.10 to 1.51)
  Pre-pregnancy dyspareunia (yes)          104   13.0 (4.6)   2.44              (1.43 to 3.44)    2.45    (1.44 to 3.46)
  Operative delivery (yes)                 92    11.7 (4.7)   0.69              (−0.38 to 1.76)   0.46    (−0.72 to 1.63)
  Smoker at inclusion (yes)‡               21    13.8 (4.9)   2.78              (0.70 to 4.86)    2.99    (0.93 to 5.06)
  Diabetes (yes)                           19    11.1 (4.9)   0.00              (−2.19 to 2.20)   −0.09   (−2.27 to 2.09)

\*PISQ-12 score, Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire, ranges 0--48, a higher score indicating a higher degree of sexual health problems; n=13 not included in analyses because of \>2 missing answers in the questionnaire.

†Adjusted for age, BMI, birth weight, duration of the second stage of labour, duration of active birth, pre-pregnancy dyspareunia, smoking, diabetes and operative delivery (second stage duration and active birth duration are not mutually adjusted for each other).

‡One missing value (n=540).

BMI, body mass index; Coef., coefficient.

After adjustment, women with anal sphincter tears had 1.69 points higher score (95% CI 0.61 to 2.76) compared with women with no/labia/first-degree tears. Women reporting pre-pregnancy dyspareunia had an average 2.45-point higher score (95% CI 1.44 to 3.46) compared with women without pre-pregnancy dyspareunia. Further, we found smoking women to have a higher PISQ-12 score compared with non-smoking women (adjusted β 2.99; 95% CI 0.93 to 5.06).

The RRs for dyspareunia postpartum according to perineal body length are presented in [table 4](#T4){ref-type="table"}.

###### 

Risk for dyspareunia according to perineal body length 12 months postpartum among primiparous women in Denmark (n=481)

  ---------------------------------------------------------------------------------------------------------------------
                              Total\   Dyspareunia   Crude        Adjusted\*                           
                              n=481                                                                    
  --------------------------- -------- ------------- ------------ ------------ ---------------- ------ ----------------
  Perineal body length (cm)                                                                            

   \>2                        468      182 (38.9)    286 (61.1)   1.00         reference        1.00   reference

   ≤2                         13       8 (61.5)      5 (38.5)     1.58         (1.02 to 2.47)   1.72   (1.10 to 2.71)
  ---------------------------------------------------------------------------------------------------------------------

\*Adjusted for age, BMI, birth weight, second stage duration, active birth duration, smoking, diabetes, operative delivery, pre-pregnancy dyspareunia and degree of tear.

BMI, body mass index; RR, relative risk.

We found women with a perineal body length ≤2 cm to be at a higher risk of dyspareunia compared with women with a perineal body length \>2 cm (aRR 1.72; 95% CI 1.10 to 2.71).

Discussion {#s4}
==========

Main findings {#s4-1}
-------------

At 12 months postpartum, more than half of the women who sustained anal sphincter tears had dyspareunia compared with one-fourth in women with no/labia/first-degree tears. Women with anal sphincter tears had a higher degree of sexual health problems in general. In addition, we found women with perineal body length ≤2 cm to be at a higher risk of dyspareunia.

Interpretation (in light of other evidence) {#s4-2}
-------------------------------------------

The literature on sexual function measured more than 6 months postpartum is in general sparse which makes it difficult to compare our results to those from other studies. Our study showed that primiparous women, regardless of degree of tear, experienced high levels of sexual health problems postpartum in accordance with the findings from another large cohort study.[@R3] In line with other studies,[@R3] we found more women with second-degree tears to have dyspareunia compared with women with no or minor tears. The same studies found pre-pregnancy dyspareunia to be associated with postpartum dyspareunia.[@R3] We observed the same association, but the association between degree of perineal tear and postpartum dyspareunia did not seem to be affected by the presence of dyspareunia before pregnancy.

Our study showed smoking women to have a higher PISQ-12 score than the non-smoking women. Studies addressing the association between smoking and female sexual health are few and results are inconsistent.[@R20] However, smoking has an anti-oestrogenic effect,[@R24] and low oestrogen levels are related to a higher prevalence of sexual health problems among women.[@R25]

There is limited knowledge on dyspareunia postpartum and the role of the pelvic floor muscles.[@R26] To the best of our knowledge, only one study including 177 women has investigated the relationship between the perineal muscles and dyspareunia and found no association.[@R26] We found the perineal length to be associated with the risk of dyspareunia. Thus, more women with a short perineum had dyspareunia.

Strengths and limitations {#s4-3}
-------------------------

The study had a high follow-up rate for both the web-based questionnaire and clinical examination.

A major strength of this study is the inclusion of only primiparous women. Hereby, we were able to assess the possible association between the degree of tear and the risk of sexual health problems without the influence of previous deliveries and tears. Further, the inclusion of a control group without perineal muscle tears made it possible to assess the effect of a vaginal delivery itself without tears to the perineal muscles. In addition, all women had a clinical examination 2 weeks postpartum, and thereby, the risk of misclassification according to exposure group was minimised.

A limitation of the present study is the fact that all clinical examinations were performed by the same examiner (DG). To limit differential misclassification, the examiner was blinded of the sexual function status of each participant and aimed to stay blinded to the degree of tear the women in question had sustained.

In the present study, we used the standardised and validated PISQ-12 questionnaire. However, the PISQ-12 questionnaire is developed and validated in populations of heterogeneous couples. The questions addressing partner erection and premature ejaculation are only relevant to women with a male partner. As the total PISQ-12 score depended on at least 10 answered questions, some women were excluded from these analyses based on their partner relationship. Thus, some of our results may only be relevant to heterosexual couples. The PISQ-12 score has a biophysical focus in general and lacks the relational and psychological issues that may have an impact on postpartum sexual health. Thus, this study does not address these issues, which are highly relevant in the context of sexual health in a vulnerable period of life.

Other studies have found an association between sexual health problems and breastfeeding, as breastfeeding might fulfil parts of a woman's need for proximity and lead to decreased oestrogen levels causing vaginal dryness.[@R27] We did not have information on breastfeeding. Yet, we have no reason to believe that breastfeeding should be unevenly distributed across degrees of perineal tears. In accordance with the results from a large Irish cohort study, we did not find episiotomies to be associated with sexual health problems 12 months postpartum.[@R19] In our primary-adjusted analyses, we included episiotomy to adjust for any potential confounding effect. Excluding episiotomy from the analyses only changed the adjusted estimates marginally, and thus, episiotomy did not seem to be a confounder in this study.

We found 19.3% to report pre-pregnancy dyspareunia. However, pre-pregnancy information was obtained 2 weeks postpartum, which might have affected the precision of the recall. Ideally, sexual function should have been established before pregnancy but this would require another study design.

Clinical implications {#s4-4}
---------------------

Although sexual problems are common 1 year after childbirth, especially among women sustaining tears of second-degree, third-degree or fourth-degree, the proportion of women who ask for help or discuss their problems is low.[@R5] Thus, it is important to give words to the sexual well-being in the postpartum assessment of women and to put a particular focus on the women at high risk of developing sexual health problems. Further, pregnancy is a time in women's life when they are in contact with health services. This provides an opportunity to identify and counsel women with dyspareunia as they are at risk of persistent sexual health problems 12 months postpartum.

If dyspareunia seems to be caused by vaginal dryness, local vaginal oestrogen or lubricants should be provided. If tender scar tissue is identified, perineal massage or use of lignocaine gel may be helpful,[@R31] and thus, new mothers should be given these advices.

Conclusion {#s5}
==========

The findings from this cohort study of primiparous women demonstrate that impairment of sexual health is common among primiparous women after vaginal delivery. Women delivering with no tears, tears isolated to the labia or small tears of first-degree reported the best outcomes overall, while more than half of the women with anal sphincter tears were experiencing dyspareunia. It is, therefore, important to minimise the extent of perineal trauma and to thoroughly counsel women and their partners about sexuality before, during and after pregnancy.
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